Analysis of Mortality in a Dermatological Affections Referral Center in Sub-Saharan Africa, Abidjan, République de Côte d'Ivoire
DOI:
https://doi.org/10.17140/DRMTOJ-1-115Keywords:
Mortality, HIV, DermatosisAbstract
Objectives: To document patients who died in Dermatology Department at University Teaching
Hospital (UTH) of Treichville; describe epidemiological aspects; indicate the various dermatological
diseases associated; specify the immediate causes; identify the determinants.
Materials and Methods: This was a cross-sectional study with descriptive and analytical referred.
Included were all hospitalized patients died in the Dermatology and Venereology service
of Treichville University Hospital from January 2000 through December 2014.
Results: One thousand seven-hundred and thirty-five patients were hospitalized. The hospital
mortality was 10.26% (178 deaths). The average age of the death was 43.16 years; the sex ratio
was 0.83. Patients who had no source of income were the most numerous (61.53%). The average
hospital stay was 20.05 days. Patients had at the entrance an altered condition in 49.43% of
cases and 46.62% in middle condition. Those who regularly bought their drugs were 58.21%.
Those who died in the second half of the month were the most numerous (55.61%). Dermatosis
groups associated deaths were: infectious dermatosis 41.57%, 29.77% tumor dermatitis
and drug eruptions 16.85%. Of the 178 deaths, the 1st 3 are pathologies associated fasciitis
(50 cases), Kaposi’s sarcoma (46 cases) and toxic epidermal necrolysis (17 cases). Respiratory
distress (41.31%) and septic shock (36.52%) were the main immediate causes of death.
Anemia (41.40%), tuberculosis (10.82%) and diabetes (10.19%) were the major comorbidities.
Serology was positive in 92.5% of dead patients who have realized their HIV status (n=80).
Significantly associated determinants were essentially the regular bought of drugs (p=0.013),
the altered condition (p=0.033), death hours (p=0.023) and comorbidities (p=00000).
Conclusion: Mortality is a reality in the Dermatology and Venereology at UTH of Treichville.
These determinants are numerous and some need to be better studied to identify true risk factors
in order to make appropriate recommendations.
References
Chalapati R, Alan DL, Yusuf H. Causes of death. In: Jamison DT, Feachem RG, Makgoba MW, et al., eds. Disease and Mor-tality in Sub-Saharan Africa. 2nd ed. Chap 5. Washington, DC, USA: World Bank; 2006.
Journet-Tollhupp J, Grange F, Bernard P. Évolution de la mor-talité dans le service de dermatologie du CHU de Reims (1996- 2009) [In French]. Annales de dermatologie et de vénérologie. 2013; 140(2): 91-96.
Keita M, Koulibaly M, Soumah MM, et al. Morbidité et mor-talité hospitalières dans le service de dermatologie-MST du CHU de Conakry (Guinée) [In French]. Annales de dermatolo-gie et de vénérologie. 2014; 141(12): 356-357.
Nair PS, Moorthy PK, Yogiragan K. A study of mortality in dermatology. Indian J Dermatol Venereol Leprol. 2005; 71: 23- 25. doi: 10.4103/0378-6323.13781
Dékou A, Ouegnin G, Konan P, et al. Contribution à l’étude de la mortalité dans un service d’urologie: Le cas du service d’uro-logie du CHU de Cocody d’Abidjan (côte d’ivoire) de 2000 à 2006 [In French]. Afr J Urol. 2009; 15(1): 44-52.
Institut National de la Statistique (Côte d’Ivoire). Résultats définitifs RGPH 2014: Indicateurs démographique [In French]. Portail INS. 2014. Web site. http://www.ins.ci/n/. Accessed Sep-tember 14, 2016.
Channon M, Hosegood V, McGrath N. A longitudinal popula-tion-based analysis of relationship status and mortality in Kwa-Zulu-Natal, South Africa 2001-2011. J Epidemiol Community Health. 2016; 70: 56-64. doi: 10.1136/jech-2014-205408
Ecra EJ, Kouassi YI, Gbéry IP, et al. Fasciitis depending on the HIV serostatus in Abidjan (Côte d’Ivoire). J Clin Exp Der-matol Res. 2014; 5: 6.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Dermatology (DER) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.